Hôpital Saint Antoine AP-HP
55 currently recruiting clinical trials
Phase 2
Colon cancer
Rectal cancer
#NCT06948448
#2024-519590-19-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
MSS/pMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Hôpital Saint Antoine AP-HP (Paris)
Ono Pharmaceutical Co. Ltd.
Phase 2
Colon cancer
Rectal cancer
#NCT04262687
Required disease stage
Metastatic
Required genetic anomalies
MSS/pMMR
Required number of previous lines of therapy for current stage of disease
None
1
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Surgery
Chemotherapy
Excluded genetic anomalies
MSI/dMMR
Excluded previous treatments at localized stage
Immunotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Hôpital Saint Antoine AP-HP (Paris)
Fédération Francophone de Cancérologie Digestive
Phase 2
Colon cancer
Rectal cancer
#NCT05310643
#2024-516313-20-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Immunotherapy
Chemotherapy
Targeted therapy
Excluded genetic anomalies
MSS/pMMR
Hôpital Saint Antoine AP-HP (Paris)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Liver and bile duct cancer
#NCT06529718
#2024-515875-36-00
Required histologic sub types
Intrahepatic cholangiocarcinoma
Extrahepatic cholangiocarcinoma
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
UNICANCER
Phase 2
Stomach and esophageal cancer
#NCT06253611
#2023-506753-38-00
Required histologic types
Stomach
Oesogastric junction
Esophagus
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
HER2
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Hôpital Saint Antoine AP-HP (Paris)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Lymphoma
#NCT04920617
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Indolent transformed lymphoma
Required central nervous system lesions
None
Treated / Controled
Required number of previous lines of therapy
2
3 or more
Required previous treatments
Chemotherapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
ImmunoVaccine Technologies, Inc.
Phase 2
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT06475352
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
UNICANCER
Phase 2
Stomach and esophageal cancer
#NCT06059495
Required histologic types
Stomach
Oesogastric junction
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Immunotherapy
Chemotherapy
Radiotherapy
Hôpital Saint Antoine AP-HP (Paris)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Stomach and esophageal cancer
Endometrial cancer
#NCT06898450
Partie C (Patients dMMR/MSI-H)
Required histologic types
Stomach
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
Nimbus Wadjet, Inc.
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06898450
Parties A and B (Patients non sélectionnés)
Required disease stage
Locally Advanced
Metastatic
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
Nimbus Wadjet, Inc.